A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer

Clinical trial NCT00445458 · COMPLETED

Trial details

NCT number: NCT00445458
Sponsor: Puma Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer Advanced Malignant Solid Tumors Breast Neoplasms

Start date: 2007-09-11
Primary completion: 2011-05-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.